PMGC Holdings Inc.
Calidad de datos: 100%
ELAB
Nasdaq
Manufacturing
Chemicals
$5.26
▲
$0.76
(16.89%)
Cap. Mercado: 10.19 M
Precio
$5.26
Cap. Mercado
10.19 M
Rango del Día
$5.25 — $7.00
Rango de 52 Semanas
$1.62 — $467.37
Volumen
57,123,683
Apertura $6.53
Promedio 50D / 200D
$8.38
37.22% below
Promedio 50D / 200D
$100.59
94.77% below
Quick Summary
Puntos Clave
Negative free cash flow of -6.38 M
Capital intensive — 74.95% of revenue goes to capex
Crecimiento
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Calidad
Return on Equity
-88.35%
Below sector avg (-51.02%)
ROICN/A
Net Margin-1313.00%
Op. MarginN/A
Seguridad
Debt / Equity
N/A
Current Ratio1.79
Interest CoverageN/A
Valoración
PE (TTM)
-1.31
Above sector avg (-1.98)
P/B Ratio1.20
EV/EBITDAN/A
Dividend YieldN/A
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Manufacturing (44 pares)
Comparación con Pares
vs mediana del sector Manufacturing (44 pares)| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | -1.3 | -2.0 |
| P/B | 1.2 | 5.1 |
| ROE % | -88.4 | -51.0 |
| Net Margin % | -1313.0 | -150.2 |
| Rev Growth 5Y % | — | 9.3 |
| D/E | — | 0.3 |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | -41.30% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 590,084.0 | Net Income (TTM) | -7.75 M |
| ROE | -88.35% | ROA | -63.73% |
| Gross Margin | 31.40% | Operating Margin | N/A |
| Net Margin | -1313.00% | Free Cash Flow (TTM) | -6.38 M |
| ROIC | N/A | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 1.79 |
| Interest Coverage | N/A | Asset Turnover | 0.05 |
| Working Capital | 4.31 M | Tangible Book Value | 4.98 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -1.31 | Forward P/E | N/A |
| P/B Ratio | 1.20 | P/S Ratio | 17.26 |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -62.59% | ||
| Market Cap | 10.19 M | Enterprise Value | 10.19 M |
| Per Share | |||
| EPS (Diluted TTM) | N/A | Revenue / Share | 0.30 |
| FCF / Share | -3.29 | OCF / Share | -3.06 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | 74.95% | FCF Conversion | 82.30% |
| SBC-Adj. FCF | -6.39 M | Growth Momentum | N/A |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Revenue | 590,084.0 | — | 1.71 M |
| Net Income | -7.75 M | -6.25 M | -4.30 M |
| EPS (Diluted) | — | — | -0.40 |
| Gross Profit | 185,314.0 | — | 1.13 M |
| Operating Income | — | — | — |
| EBITDA | — | — | — |
| R&D Expenses | 147,010.0 | 104,654.0 | 426,243.0 |
| SG&A Expenses | — | — | — |
| D&A | 96,145.0 | — | — |
| Interest Expense | 103,294.0 | 735,197.0 | 19,525.0 |
| Income Tax | 30,972.0 | — | — |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Total Assets | 12.87 M | 8.99 M | 5.19 M |
| Total Liabilities | 5.03 M | 2.33 M | 1.36 M |
| Shareholders' Equity | 7.84 M | 6.66 M | 3.83 M |
| Total Debt | — | — | — |
| Cash & Equivalents | — | 3.98 M | — |
| Current Assets | 6.87 M | 6.05 M | 4.92 M |
| Current Liabilities | 3.94 M | 1.80 M | 1.30 M |
{"event":"ticker_viewed","properties":{"ticker":"ELAB","listing_kind":"stock","pathname":"/stocks/elab","exchange":"Nasdaq","country":"US"}}